Spicing Up the Gut Health: Therapeutic Potential of Cinnamon in Gut Inflammation and Fibrosis
Intestinal fibrosis (IF) is considered a chronic, immune-mediated, and progressive disorder associated with inflammatory bowel disease (IBD). Intestinal fibrosis is characterized by excessive extracellular matrix deposition and tissue remodeling that can result in bowel strictures, obstruction, and significant morbidity. Unlike inflammation, fibrosis is largely irreversible and remains a critical unmet clinical challenge. Currently, there are no effective antifibrotic therapies, and surgical interventions that are unable to render a cure or remission remain the primary treatment option. Furthermore, these procedures are associated with considerable risks, including postoperative recurrence and progressive bowel shortening. Therefore, effective and safer treatments for intestinal fibrosis are warranted and the key focus of the research. In this regard, cinnamon, a widely used medicinal spice, possesses anti-inflammatory, antioxidant, antimicrobial, and immunomodulatory properties. Recent studies show that cinnamon and its bioactive components suppress pro-inflammatory signaling pathways, modulate gut microbiota, enhance epithelial barrier integrity, and regulate extracellular matrix (ECM) remodeling. These effects suggest that cinnamon may attenuate intestinal fibrosis by disrupting the mechanisms underlying fibrogenesis. Therefore, this review summarizes current knowledge of intestinal fibrosis pathogenesis and highlights evidence of cinnamon as a potential therapeutic supplement to treat and/or manage intestinal fibrosis.
Authors
- Krish O. Pahan
- Anoop Kumar (ORCID: https://orcid.org/0000-0001-7915-3365)
- Samantha Wu (ORCID: https://orcid.org/0009-0007-0405-9201)
Institutions
- University of Illinois Urbana-Champaign (US)
- University of Illinois Chicago (US)
- Jesse Brown VA Medical Center (US)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/ijms272210349
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Veterans Affairs